Compare UHT & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UHT | FLGT |
|---|---|---|
| Founded | 1986 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.9M | 697.3M |
| IPO Year | N/A | 2016 |
| Metric | UHT | FLGT |
|---|---|---|
| Price | $42.29 | $27.12 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $28.33 |
| AVG Volume (30 Days) | 105.3K | ★ 265.4K |
| Earning Date | 10-27-2025 | 11-07-2025 |
| Dividend Yield | ★ 6.97% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.30 | N/A |
| Revenue | $100,898,000.00 | ★ $315,549,000.00 |
| Revenue This Year | $0.71 | $16.84 |
| Revenue Next Year | $2.00 | $9.74 |
| P/E Ratio | $32.49 | ★ N/A |
| Revenue Growth | 1.00 | ★ 13.61 |
| 52 Week Low | $34.56 | $14.57 |
| 52 Week High | $43.00 | $31.04 |
| Indicator | UHT | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 68.57 | 47.00 |
| Support Level | $39.44 | $26.69 |
| Resistance Level | $41.19 | $31.04 |
| Average True Range (ATR) | 0.88 | 0.77 |
| MACD | 0.13 | -0.46 |
| Stochastic Oscillator | 81.04 | 10.80 |
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.